In an immunohistochemical analysis conducted by Huang et al. on 21 vestibular schwannoma specimens associated with neurofibromatosis type 2, VEGF was found to be expressed in 100% of the vestibular schwannomas, and VEGFR-2 was expressed in 32% of the tumor blood vessels [84]. This evidence concerns the gene VEGFA and neoplasm.